central venous catheter

From Aaushi
Jump to navigation Jump to search

Indications

Contraindications

Benefit/risk

Caution:

Procedure

approaches*

* the most effective means of preventing complications is ultrasound-guided internal jugular catheterization, with daily assessment for continued need

* 2-dimensional ultrasound helps with vein localization[3]; reduces procedure failure, vessel injury, pneumothorax[5]

Complications

* pneumothorax can be diagnosed promptly & treated immediately intravascular catheter-related infection or deep-vein thrombosis may be more problematic[10]

* also see Procedure: (above)

Management

Notes

More general terms

More specific terms

Additional terms

References

  1. Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 246-48
  2. Journal Watch 21(18):144, 2001
    Merrer J, De Jonghe B, Golliot F et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001 Aug 10; 286:700. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11495620
  3. 3.0 3.1 Journal Watch 23(20):163, 2003
    Hind D, Calvert N, McWilliams R et al Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ. 2003 Aug 16;327(7411):361. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/12919984 Free PMC Article <Internet> http://bmj.bmjjournals.com/cgi/content/full/327/7411/361
  4. 4.0 4.1 Timsit J-F et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 2012 Dec 15; 186:1272. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23043083
  5. 5.0 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 5.9 Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 18, 19. American College of Physicians, Philadelphia 2012, 2015, 2018, 2021.
  6. 6.0 6.1 6.2 Hoggard J, Saad T, Schon D et al Guidelines for venous access in patients with chronic kidney disease. A Position Statement from the American Society of Diagnostic and Interventional Nephrology, Clinical Practice Committee and the Association for Vascular Access. Semin Dial. 2008 Mar-Apr;21(2):186-91 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18364015
  7. 7.0 7.1 Horowitz R et al. The FLUSH study - Flush the Line and Ultrasound the Heart: Ultrasonographic confirmation of central femoral venous line placement. Ann Emerg Med 2014 Jan 17 PMID: https://www.ncbi.nlm.nih.gov/pubmed/24439714
  8. 8.0 8.1 8.2 Chopra V et al Do Clinicians Know Which of Their Patients Have Central Venous Catheters?: A Multicenter Observational Study. Ann Intern Med. 2014;161(8):562-567 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25329204 <Internet> http://annals.org/article.aspx?articleid=1916822
    Taichman DB Whose Line Is It Anyway? Ann Intern Med. 2014;161(8):607-608 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25329208 <Internet> http://annals.org/article.aspx?articleid=1916831
  9. 9.0 9.1 The NNT: Subclavian vs. Femoral Central Line Placement. http://www.thennt.com/nnt/subclavian-vs-femoral-central-line-placement/
    Hamilton HC, Foxcroft DR. Central venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring long-term intravenous therapy. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004084. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17636746
  10. 10.0 10.1 10.2 Parienti JJ et al Intravascular Complications of Central Venous Catheterization by Insertion Site. N Engl J Med 2015; 373:1220-1229. September 24, 2015. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26398070 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1500964
  11. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003 Mar 21; 348:1123 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/12646670 Free full text <Internet> http://www.nejm.org/doi/full/10.1056/NEJMra011883
  12. 12.0 12.1 Schulman PM, Gerstein NS, Merkel MJ et al Ultrasound-Guided Cannulation of the Subclavian Vein. N Engl J Med 2018; 379:e1. July 5, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29972747 https://www.nejm.org/doi/full/10.1056/NEJMvcm1406114
  13. 13.0 13.1 Swaminathan L, Flanders S, Horowitz J et al. Safety and outcomes of midline catheters vs peripherally inserted central catheters for patients with short-term indications: A multicenter study. JAMA Intern Med 2022 Jan; 182:50-58. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34842905 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2786212
  14. 14.0 14.1 van Baarle FLF et al. Platelet transfusion before CVC placement in patients with thrombocytopenia. N Engl J Med 2023 May 25; 388:1956. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37224197 https://www.nejm.org/doi/10.1056/NEJMoa2214322
  15. 15.0 15.1 Teja B et al. Complication rates of central venous catheters: A systematic review and meta-analysis. JAMA Intern Med 2024 Mar 4; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38436976 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2815818
  16. 16.0 16.1 Corley A, Royle RH, Marsh N et al. Incidence and risk factors for central venous access device failure in hospitalized adults: A multivariable analysis of 1892 catheters. J Hosp Med 2024 Oct; 19:905 PMID: https://www.ncbi.nlm.nih.gov/pubmed/38800854 https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.13414